Cargando…
Early-Life Host–Microbiome Interphase: The Key Frontier for Immune Development
Human existence can be viewed as an “animal in a microbial world.” A healthy interaction of the human host with the microbes in and around us heavily relies on a well-functioning immune system. As development of both the microbiota and the host immune system undergo rapid changes in early life, it i...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442244/ https://www.ncbi.nlm.nih.gov/pubmed/28596951 http://dx.doi.org/10.3389/fped.2017.00111 |
_version_ | 1783238368263405568 |
---|---|
author | Amenyogbe, Nelly Kollmann, Tobias R. Ben-Othman, Rym |
author_facet | Amenyogbe, Nelly Kollmann, Tobias R. Ben-Othman, Rym |
author_sort | Amenyogbe, Nelly |
collection | PubMed |
description | Human existence can be viewed as an “animal in a microbial world.” A healthy interaction of the human host with the microbes in and around us heavily relies on a well-functioning immune system. As development of both the microbiota and the host immune system undergo rapid changes in early life, it is not surprising that even minor alterations during this co-development can have profound consequences. Scrutiny of existing data regarding pre-, peri-, as well as early postnatal modulators of newborn microbiota indeed suggest strong associations with several immune-mediated diseases with onset far beyond the newborn period. We here summarize these data and extract overarching themes. This same effort in turn sets the stage to guide effective countermeasures, such as probiotic administration. The objective of our review is to highlight the interaction of host immune ontogeny with the developing microbiome in early life as a critical window of susceptibility for lifelong disease, as well as to identify the enormous potential to protect and promote lifelong health by specifically targeting this window of opportunity. |
format | Online Article Text |
id | pubmed-5442244 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-54422442017-06-08 Early-Life Host–Microbiome Interphase: The Key Frontier for Immune Development Amenyogbe, Nelly Kollmann, Tobias R. Ben-Othman, Rym Front Pediatr Pediatrics Human existence can be viewed as an “animal in a microbial world.” A healthy interaction of the human host with the microbes in and around us heavily relies on a well-functioning immune system. As development of both the microbiota and the host immune system undergo rapid changes in early life, it is not surprising that even minor alterations during this co-development can have profound consequences. Scrutiny of existing data regarding pre-, peri-, as well as early postnatal modulators of newborn microbiota indeed suggest strong associations with several immune-mediated diseases with onset far beyond the newborn period. We here summarize these data and extract overarching themes. This same effort in turn sets the stage to guide effective countermeasures, such as probiotic administration. The objective of our review is to highlight the interaction of host immune ontogeny with the developing microbiome in early life as a critical window of susceptibility for lifelong disease, as well as to identify the enormous potential to protect and promote lifelong health by specifically targeting this window of opportunity. Frontiers Media S.A. 2017-05-24 /pmc/articles/PMC5442244/ /pubmed/28596951 http://dx.doi.org/10.3389/fped.2017.00111 Text en Copyright © 2017 Amenyogbe, Kollmann and Ben-Othman. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pediatrics Amenyogbe, Nelly Kollmann, Tobias R. Ben-Othman, Rym Early-Life Host–Microbiome Interphase: The Key Frontier for Immune Development |
title | Early-Life Host–Microbiome Interphase: The Key Frontier for Immune Development |
title_full | Early-Life Host–Microbiome Interphase: The Key Frontier for Immune Development |
title_fullStr | Early-Life Host–Microbiome Interphase: The Key Frontier for Immune Development |
title_full_unstemmed | Early-Life Host–Microbiome Interphase: The Key Frontier for Immune Development |
title_short | Early-Life Host–Microbiome Interphase: The Key Frontier for Immune Development |
title_sort | early-life host–microbiome interphase: the key frontier for immune development |
topic | Pediatrics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442244/ https://www.ncbi.nlm.nih.gov/pubmed/28596951 http://dx.doi.org/10.3389/fped.2017.00111 |
work_keys_str_mv | AT amenyogbenelly earlylifehostmicrobiomeinterphasethekeyfrontierforimmunedevelopment AT kollmanntobiasr earlylifehostmicrobiomeinterphasethekeyfrontierforimmunedevelopment AT benothmanrym earlylifehostmicrobiomeinterphasethekeyfrontierforimmunedevelopment |